In Vitro Market (IVD) Market Trends in 2024 and Beyond
The in vitro diagnostics (IVD) sector is undergoing significant transformation despite a decline in COVID-19 diagnostics. This shift is driven by increased awareness of early disease detection, personalized medicine, and precise healthcare interventions. Technological advancements, particularly in artificial intelligence (AI) and molecular diagnostics, are enhancing diagnostic accuracy and efficiency. The market is also seeing a rise in point-of-care testing (POCT) and rapid diagnostic solutions. Despite challenges like regulatory compliance and cost containment, the IVD market is poised for growth due to rising chronic illnesses, aging populations, and a focus on preventative healthcare.